HUP1000284A3 - Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation - Google Patents

Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Info

Publication number
HUP1000284A3
HUP1000284A3 HU1000284A HUP1000284A HUP1000284A3 HU P1000284 A3 HUP1000284 A3 HU P1000284A3 HU 1000284 A HU1000284 A HU 1000284A HU P1000284 A HUP1000284 A HU P1000284A HU P1000284 A3 HUP1000284 A3 HU P1000284A3
Authority
HU
Hungary
Prior art keywords
pgf1
medicament
alpha
derivatives
preparation
Prior art date
Application number
HU1000284A
Other languages
Hungarian (hu)
Original Assignee
Avidin Kft
Ubichem Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avidin Kft, Ubichem Kft filed Critical Avidin Kft
Priority to HU1000284A priority Critical patent/HUP1000284A3/en
Publication of HU1000284D0 publication Critical patent/HU1000284D0/en
Priority to PCT/HU2011/000050 priority patent/WO2011154754A1/en
Publication of HUP1000284A2 publication Critical patent/HUP1000284A2/en
Publication of HUP1000284A3 publication Critical patent/HUP1000284A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU1000284A 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation HUP1000284A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation
PCT/HU2011/000050 WO2011154754A1 (en) 2010-06-01 2011-06-01 USE OF PROSTAGLANDIN F1α AND ITS DERIVATIVES FOR REDUCTION OF INFLAMMATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Publications (3)

Publication Number Publication Date
HU1000284D0 HU1000284D0 (en) 2010-07-28
HUP1000284A2 HUP1000284A2 (en) 2012-03-28
HUP1000284A3 true HUP1000284A3 (en) 2012-08-28

Family

ID=89989751

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1000284A HUP1000284A3 (en) 2010-06-01 2010-06-01 Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation

Country Status (2)

Country Link
HU (1) HUP1000284A3 (en)
WO (1) WO2011154754A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954741A (en) * 1972-06-07 1976-05-04 Pfizer Inc. N-substituted prostaglandin carboxamides
US4122282A (en) * 1975-12-29 1978-10-24 The Upjohn Company 2-Decarboxy-2-carboxyamino-methyl-PGFα compounds
WO2003092617A2 (en) * 2002-05-03 2003-11-13 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
EP2007705A4 (en) * 2006-03-29 2011-09-07 Nicox Sa Nitric oxide enhancing prostaglandin compounds, compositions and methods of use

Also Published As

Publication number Publication date
HUP1000284A2 (en) 2012-03-28
WO2011154754A1 (en) 2011-12-15
HU1000284D0 (en) 2010-07-28

Similar Documents

Publication Publication Date Title
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
IL221132A0 (en) Derivatives of betulin
HUP1000069A2 (en) New salts for the preparation of pharmaceutical composition
EP2586448A4 (en) Skin properties improving agent for oral administration
HK1200366A1 (en) Pharmaceutical compositions and methods of use of 4-pregenen-11ss-17- 21-triol-3,20-dione derivatives 4--11-17-21--320-
PL2642993T3 (en) Compositions of rotigotine or pharmaceutically acceptable salts of rotigotine
ME03769B (en) New form of administration of racecadotril
SG10201505752QA (en) Use of proanthocyanidin b2 for preparing medicaments
IL223311A0 (en) Oral dosage forms of bendamustine
HK1188791A1 (en) Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
ZA201208775B (en) Gel formulations for the topical use of 1-amino-alkycyclohexane derivatives
GB201001203D0 (en) Use of pharmaceutically active compounds
EP2536688A4 (en) Stable dosage forms of levomilnacipran
HUP1000284A2 (en) Use of derivatives of pgf1-alpha for preparation of medicament for reducing inflammation
HK1181773A1 (en) 4-alkylresorcinol derivative and external preparation for skin containing same 4-
ZA201304079B (en) Dosages of arylsulfonamide derivatives
GB201104632D0 (en) Use of medicament
GB201010671D0 (en) Compounds for treatment of inflammation
GB201005495D0 (en) Compounds for treatment of inflammation
GB201004479D0 (en) Therapeutic use of new compounds I
GB201009614D0 (en) Therapeutic use of compounds
GB201108673D0 (en) Colour stability of dual medicament dressings
GB201004480D0 (en) Therapeutic use of new compounds II

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees